Literature DB >> 27832390

Monitoring of the HIV Epidemic Using Routinely Collected Data: The Case of the United Kingdom.

Brian D Rice1, Zheng Yin2, Alison E Brown2, Sara Croxford2, Stefano Conti2, Daniela De Angelis2, Valerie C Delpech2.   

Abstract

We report on measures used to monitor the response to the UK HIV epidemic. We present analyses of routine data on HIV testing, diagnosis and care, and of CD4 back-calculation models to estimate country of HIV acquisition and incidence. Over the past decade, HIV and AIDS diagnoses and deaths declined while HIV testing coverage increased. Linkage into care, retention in care, and viral suppression was high with few socio-demographic differences. However, in 2013, incidence among MSM, and undiagnosed infection, also remained high, and more than half of heterosexuals newly diagnosed with HIV (the majority of whom were born-abroad) probably acquired HIV in the UK and were diagnosed late. HIV care following diagnosis is excellent in the UK. Improvements in testing and prevention are required to reduce undiagnosed infection, incidence and late diagnoses. Routinely collected laboratory and clinic data is a low cost, robust and timely mechanism to monitor the public health response to national HIV epidemics.

Entities:  

Keywords:  Case reporting; Epidemiology; HIV surveillance; Heterosexuals; Men who have sex with men; Monitoring; United Kingdom

Mesh:

Year:  2017        PMID: 27832390     DOI: 10.1007/s10461-016-1604-6

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  7 in total

1.  Feasibility of Establishing HIV Case-Based Surveillance to Measure Progress Along the Health Sector Cascade: Situational Assessments in Tanzania, South Africa, and Kenya.

Authors:  Richelle Harklerode; Sandra Schwarcz; James Hargreaves; Andrew Boulle; Jim Todd; Serge Xueref; Brian Rice
Journal:  JMIR Public Health Surveill       Date:  2017-07-10

2.  Fall in new HIV diagnoses among men who have sex with men (MSM) at selected London sexual health clinics since early 2015: testing or treatment or pre-exposure prophylaxis (PrEP)?

Authors:  Alison E Brown; Hamish Mohammed; Dana Ogaz; Peter D Kirwan; Mandy Yung; Sophie G Nash; Martina Furegato; Gwenda Hughes; Nicky Connor; Valerie C Delpech; O Noel Gill
Journal:  Euro Surveill       Date:  2017-06-22

3.  The use of funnel plots with regression as a tool to visually compare HIV treatment outcomes between centres adjusting for patient characteristics and size: a UK Collaborative HIV Cohort study.

Authors:  M Gompels; S Michael; S Jose; T Hill; R Trevelion; C A Sabin; M T May
Journal:  HIV Med       Date:  2018-04-14       Impact factor: 3.180

4.  Estimation of delay to diagnosis and incidence in HIV using indirect evidence of infection dates.

Authors:  Oliver T Stirrup; David T Dunn
Journal:  BMC Med Res Methodol       Date:  2018-06-27       Impact factor: 4.615

5.  Predictive factors for HIV infection among men who have sex with men and who are seeking PrEP: a secondary analysis of the PROUD trial.

Authors:  Ellen White; David T Dunn; Monica Desai; Mitzy Gafos; Peter Kirwan; Ann K Sullivan; Amanda Clarke; Sheena McCormack
Journal:  Sex Transm Infect       Date:  2019-03-27       Impact factor: 3.519

6.  Linkage of Whole Genome Sequencing, Epidemiological, and Clinical Data to Understand the Genetic Diversity and Clinical Outcomes of Shigella flexneri among Men Who Have Sex with Men in England.

Authors:  Nigel Field; Gwenda Hughes; Holly D Mitchell; Nicholas R Thomson; Claire Jenkins; Timothy J Dallman; Anaïs Painset; Peter Kirwan; Valerie Delpech; Amy F W Mikhail
Journal:  Microbiol Spectr       Date:  2021-12-15

7.  Towards standardized definitions for monitoring the continuum of HIV care in Europe.

Authors:  Annabelle J Gourlay; Anastasia M Pharris; Teymur Noori; Virginie Supervie; Magdalena Rosinska; Ard van Sighem; Giota Touloumi; Kholoud Porter
Journal:  AIDS       Date:  2017-09-24       Impact factor: 4.177

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.